Instrumento Inactivo

Acciones Genentech, Inc.

Acciones

Precio de cierre Nyse Otros sitios de cotización
- ^USD	-

Roche: la FDA homologue Venetoclax pour traiter une sorte de leucémie	12/04/16
Roche erhält von FDA Zulassung für Venetoclax zur Behandlung von Leukämie-Art	11/04/16
Fortescue Metals Group Limited Reports Unaudited Consolidated Earnings and Production Results for the Half Year Ended December 31, 2014; Provides Production Guidance for the Full Year of Fiscal 2015; Declares Fully Franked Interim Dividend for the Half Year Ended December 31, 2014, Payable on April 7, 2015	16/02/15
Genentech, Inc. : Dalradian Appoints Chief Operating Officer	20/04/11
Genentech, Inc. : Dalradian Appoints Chief Operating Officer	20/04/11

Sector